Lotus Pharms Inc (LTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Sales | 14,949 | 17,856 | 14,513 | 13,632 | 11,824 |
| Cost of Goods | 6,240 | N/A | 5,990 | 5,740 | N/A |
| Gross Profit | 8,700 | 17,856 | 8,520 | 7,880 | 11,824 |
| Operating Expenses | 3,430 | 0 | 3,490 | 3,310 | 0 |
| Operating Income | 5,519 | 17,856 | 6,023 | 5,322 | 11,824 |
| Interest Expense | 430 | 0 | 430 | 470 | 0 |
| Other Income | -59 | 0 | -133 | -62 | 0 |
| Pre-tax Income | 5,030 | 17,856 | 5,460 | 4,790 | 11,824 |
| Income Tax | 100 | N/A | 70 | 7 | N/A |
| Net Income Continuous | 4,929 | 2,688 | 5,391 | 4,786 | 3,568 |
| Net Income | $4,929 | $2,688 | $5,391 | $4,786 | $3,568 |
| EPS Basic Total Ops | 0.20 | 0.10 | 0.24 | 0.22 | 0.16 |
| EPS Basic Continuous Ops | 0.20 | 0.10 | 0.25 | 0.22 | 0.17 |
| EPS Diluted Total Ops | 0.18 | 0.10 | 0.22 | 0.20 | 0.14 |
| EPS Diluted Continuous Ops | 0.18 | 0.10 | 0.22 | 0.19 | 0.14 |
| EBITDA(a) | $6,159 | $19,176 | $6,023 | $5,322 | $11,824 |